Skip to main content
Skip to main content
AVCRF logo

Avricore Health Inc. (AVCRF) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.0008 $0.00 (0.00%) |CouncilSplit View · 48 · C
Vol: 6.0K|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Avricore Health Inc. (AVCRF) trades at $0.0008. Avricore Health Inc. operates in the health technology sector, focusing on point-of-care testing and data analytics within pharmacies. The company's key product is HealthTab, a platform providing in-pharmacy testing services.

Price as of Sep 11, 2026 · Last analyzed: Sep 10, 2026

Avricore Health Inc. operates in the health technology sector, focusing on point-of-care testing and data analytics within pharmacies. The company's key product is HealthTab, a platform providing in-pharmacy testing services. A potential strength lies in the growing demand for accessible and convenient healthcare solutions. However, the company faces risks inherent to the OTC market, including limited liquidity and regulatory hurdles. Investors should closely monitor the company's progress in expanding its pharmacy network and achieving sustained profitability.

Analyst Coverage for AVCRF: AVCRF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates AVCRF against sector peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the AVCRF film Every key number, told as a short cinematic story — just press play. ~2 min

No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.

Council Score · Weighted Average of 3 Disciplines
Split View 48/100 · C

AVCRF: 1/2 scored disciplines lean bearish. Dominant signal: Izzy Englander bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Simons-style lens (simulated)Jim Simons
Neutral read
Englander-style lens (simulated)Izzy Englander
Favorable read
Klarman-style lens (simulated)Seth Klarman
Unfavorable read
Moon AI lens (model)
Neutral read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Negative
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Avricore Health Inc. Company Overview

Data Provenance | Financial Data Quantitative Analysis

Research confidence

Low 20/100

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • Scoring coverage unknown
  • Price is current
  • No filing on record
  • No analyst coverage

AVCRF Current Price & Trading Activity

AVCRF is currently trading at $0.00, with a daily change of +0.00 (+0.00%). The stock has a trading volume of 6.0K shares, which provides insight into market interest and liquidity for this security.

Analyst Coverage for AVCRF

AVCRF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model scores AVCRF on quantitative fundamentals — growth, financial health, valuation, and momentum — relative to sector peers and assigns a neutral fundamental signal based on the underlying data. Investors monitoring AVCRF should weigh peer-relative metrics and sector momentum more heavily until institutional coverage emerges.

Data sourced from Financial Modeling Prep, Yahoo Finance and SEC EDGAR. This content is generated from market data and is not financial advice. Past performance does not guarantee future results.

AVCRF Latest News

No recent news available for AVCRF.

AVCRF Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for AVCRF.

Price Targets

Wall Street price target analysis for AVCRF.

AVCRF MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for AVCRF; grades run from A+ (80-100) to F (below 30).

AVCRF OTC Market Information

AVCRF trades on the OTC Other market tier of OTC Markets.

  • OTC Tier: OTC Other

Investor Questions: AVCRF Stock

Is AVCRF a good stock?

Stock Expert AI does not rate AVCRF buy, sell or hold. Avricore Health Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What are the key factors to evaluate for AVCRF?

Evaluate AVCRF on fundamentals, analyst consensus, and risk factors. Not financial advice.

How frequently does AVCRF data refresh on this page?

AVCRF's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven AVCRF's recent stock price performance?

Avricore Health Inc. (AVCRF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider AVCRF overvalued or undervalued right now?

Avricore Health Inc. (AVCRF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of AVCRF?

Yes, most major brokerages offer fractional shares of Avricore Health Inc. (AVCRF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track AVCRF's earnings and financial reports?

Avricore Health Inc. (AVCRF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for AVCRF earnings announcements.

What should investors new to AVCRF understand first?

Avricore Health Inc. (AVCRF) is worth researching across volatility, fundamentals, and industry context. Start with the Company Overview and MoonshotScore tabs for a structured introduction.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

More Stocks We Cover